EPIVIR-HBV Reviews (LAMIVUDINE)

Average Rating: 4.0 (3 Ratings)

Filter Results

Compare EPIVIR-HBV with similar:
 ANTIVIRALS

 Type: Rx Drug

  

EPIVIR-HBV  (LAMIVUDINE):  Lamivudine-HBV is used to treat hepatitis B infection. It is not a cure for hepatitis B and does not prevent the passing of hepatitis B to others. This medication is a nucleoside reverse transcriptase inhibitor (NRTI) that works by slowing the growth of the virus, thereby decreasing liver damage caused by the virus.   FDA Approval Date: 1998-12-08 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR EPIVIR-HBVCOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 3  Chronic HBV No side effects Developed lamivudine-resistant HBV (YMDD) after only 8 months. I am Genotype C, eAG positive, but confirmed precore mutant by testing. M 38 12 months
 1/7/2008
 5   M 29 7 months
 4/1/2005
 4  hepatitis B first 3 month light headache, next 6 months malaise/fatigue, 6th to 9th month hair loss, terrible nails easy to take-just one pill a day, but without insurance pricey F 35 9 months
 1/31/2005
  

EPIVIR-HBV  (LAMIVUDINE):  Lamivudine-HBV is used to treat hepatitis B infection. It is not a cure for hepatitis B and does not prevent the passing of hepatitis B to others. This medication is a nucleoside reverse transcriptase inhibitor (NRTI) that works by slowing the growth of the virus, thereby decreasing liver damage caused by the virus.   FDA Approval Date: 1998-12-08 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP